
News|Articles|August 21, 2015
Suresh Ramalingam on Toxicities Associated With Immunotherapy in Different Disease Types
Author(s)Suresh S. Ramalingam
Key Takeaways
- Immunotherapy offers significant advantages over traditional cancer treatments but presents unique toxicity profiles requiring distinct management strategies.
- Immune-related toxicities can affect various organ systems, necessitating vigilant monitoring and intervention by oncologists.
Suresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, comments on the difference in toxicities associated with immunotherapy.
Advertisement
Suresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, comments on the difference in toxicities associated with immunotherapy.
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
Delving into Recent Advancements in Lung Cancer Care
2
Making Breast Cancer Surgery Easier and Faster to Recover From
3
Understanding Minimally Invasive Lung Cancer Care Advancements
4
Expert Shares Advice for Navigating a New Lung Cancer Diagnosis
5




